Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146414 | SCV000193700 | pathogenic | Severe X-linked myotubular myopathy | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000523062 | SCV000617413 | pathogenic | not provided | 2023-12-21 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9305655, 34366366, 11793470, 12522554, 18358876, 25525159, 33333461, 31069529) |
Labcorp Genetics |
RCV000146414 | SCV000634488 | pathogenic | Severe X-linked myotubular myopathy | 2023-03-29 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 158935). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg474*) in the MTM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTM1 are known to be pathogenic (PMID: 9305655, 10063835). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with myotubular myopathy (PMID: 9305655, 11793470, 18358876, 25957634). |
Revvity Omics, |
RCV000523062 | SCV004236958 | pathogenic | not provided | 2019-04-12 | criteria provided, single submitter | clinical testing |